Is there a line in the sand for the BOJ — a threshold for yen depreciation that policymakers will defend?...
Biopharma and life sciences hedge funds posted mixed results in May in what is a very volatile strategy. As a...
Negative gearing gets talked about a lot in debates about housing and the federal budget, but it is not always...
